- The Life Technologies Corporation (former Invitrogen IP Holdings, Inc.) and RIKEN BRC have signed a license agreement on July 2, 2009. With generosity of Life Technologies Corporation, Riken BRC is now able to receive, maintain, replicate and distribute Gateway® Entry clones and Expression clones for not-for-profit academic research under this agreement.
- The Entry clone harboring cDNA can be distributed for not-for-profit academic research without any license fees. The Expression clone harboring mammalian cDNA can be distributed from the RIKEN BRC for not-for-profit academic research with a small amount of license fee to the Life Technologies Corporation. In addition to the regular fee for a cDNA clone, users are asked to pay RIKEN BRC 1,250 YEN per clone that includes the license fee, handling of currency exchange, money transfer and other expense. Every six months, RIKEN BRC will report to Life Technologies Corporation a number of distributions of Entry and Expression clones and send a sum of license fee for Expression clones. Any commercial users of the Gateway® Entry or Expression clones must contact Life Technologies Corporation for prior written approval.
- RIKEN BRC has set the Material Transfer Agreements (MTA) for each transfer to protect the intellectual property rights of developers of bioresources and to define the responsibility of users. We have opened a path of the not-for-profit academic use of bioresources produced by using research tools owned by commercial entities.
- Deposition of bioresources to the RIKEN BRC frees researchers from cumbersome preservation and distribution of materials fellow researchers. Furthermore, deposition increases chance of collaboration and citation of research paper. Your deposition of genetic resources in particular the Gateway® clones to the Gene Engineering Division is most appreciated.
- Please download and read the Limited Use Label License: No.19 (Gateway® Cloning Products) [PDF]
(frmegtwy 2009.11.03 T.M.)